References
- Chopra R, Blair S, Strang J, Cervi P, Patterson K G, Goldstone A H. Lipsomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. J Antimicrob Chemother 1991; 28: 93–104, Suppl B
- Johnson D E, Thompson T R, Green T P, Ferrieri P. Systemic Candidiasis in very low birth weight infants (< 1500 grams). Pediatrics 1984; 73: 138–143
- Butler K M, Baker C J. Candida: An increasingly important pathogen in the nursery. Pediatr Clin North Am 1988; 35: 543–563
- Vincent M, Webster M H, Pether J VS. Lancet 1992; 339: 374–375
- Tollemar J, Duraj F, Ericzon B G. Liposomal amphotericin B treatment in a 9-month-old liver recipient. Mycoses, 33: 251–252
- Lackner H, Schwinger W, Urban C, Müller W, Ritschl E, Retterer F, Kuttnig-Haim M, Urlesberger B, Hauer C. Liposomal amphotericin B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics 1992; 89: 1259–1261
- Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey G P. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Eur J Clin Microbiol Infect Dis 1991; 10: 665–668
- Pahls S, Schnaffner A. Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis. J Infect Dis 1994; 169: 1057–1061
- Walsh T J, Pizzo A. Treatment of systemic fungal infections: Recent progress and current problems. Eur J Clin Microbiol Infect Dis 1988; 7: 460–475